GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins November 21, 2024
Displaying entries 4751 - 4800 of 39437 in total
PDB ID UniProt ID Title Descriptor ▼
6ZJM 6ZJM Atomic model of Andes virus glycoprotein spike tetramer generated by fitting into a Tula virus reconstruction Envelope polyprotein,Envelope polyprotein,Envelope polyprotein
6YRB Q9E006 Crystal structure of the tetramerization domain of the glycoprotein Gn (Andes virus) at pH 7.5 Envelope polyprotein,Envelope polyprotein
7B0A Q9WJ31 Puumala virus-like particle glycoprotein spike and lattice contacts model. Envelope polyprotein
6HRO Q05320 Crystal structure of Ebolavirus glycoprotein in complex with inhibitor 118a Envelope glycoprotein,Envelope glycoprotein,Envelope glycoprotein, Envelope glycoprotein
6G9B Q05320 Crystal structure of Ebolavirus glycoprotein in complex with imipramine Envelope glycoprotein,Envelope glycoprotein, Envelope glycoprotein
6G9I Q05320 Crystal structure of Ebolavirus glycoprotein in complex with clomipramine Envelope glycoprotein,Envelope glycoprotein
6G9I M1E1E4 Crystal structure of Ebolavirus glycoprotein in complex with clomipramine Envelope glycoprotein,Envelope glycoprotein
5HJ3 5HJ3 Crystal structure of host-primed Ebola virus GP, GPcl. Envelope glycoprotein, KZ52 Antibody Fragment
5HJ3 Q05320 Crystal structure of host-primed Ebola virus GP, GPcl. Envelope glycoprotein, KZ52 Antibody Fragment
5HJ3 P87666 Crystal structure of host-primed Ebola virus GP, GPcl. Envelope glycoprotein, KZ52 Antibody Fragment
6DZM B8XCN0 Bundibugyo virus GP (mucin-deleted) in complex with pan-ebolavirus human antibody ADI-15878 Fab Envelope glycoprotein, Glycoprotein, Antibody ADI-15878 Fab, light chain, Antibody ADI-15878 Fab, heavy chain
6DZM 6DZM Bundibugyo virus GP (mucin-deleted) in complex with pan-ebolavirus human antibody ADI-15878 Fab Envelope glycoprotein, Glycoprotein, Antibody ADI-15878 Fab, light chain, Antibody ADI-15878 Fab, heavy chain
6UM7 Q2N0S7 Cryo-EM structure of vaccine-elicited HIV-1 neutralizing antibody DH270.mu1 in complex with CH848 10.17DT Env Envelope glycoprotein gp41, Envelope glycoprotein gp120, DH270.mu1 Fab Heavy Chain, DH270.mu1 Fab Light chain
6UM7 A0A1W6IPB2 Cryo-EM structure of vaccine-elicited HIV-1 neutralizing antibody DH270.mu1 in complex with CH848 10.17DT Env Envelope glycoprotein gp41, Envelope glycoprotein gp120, DH270.mu1 Fab Heavy Chain, DH270.mu1 Fab Light chain
6UM7 6UM7 Cryo-EM structure of vaccine-elicited HIV-1 neutralizing antibody DH270.mu1 in complex with CH848 10.17DT Env Envelope glycoprotein gp41, Envelope glycoprotein gp120, DH270.mu1 Fab Heavy Chain, DH270.mu1 Fab Light chain
6UM5 A0A1W6IPB2 Cryo-EM structure of HIV-1 neutralizing antibody DH270 UCA3 in complex with CH848 10.17DT Env Envelope glycoprotein gp41, Envelope glycoprotein gp120, DH270 UCA3 Fab heavy chain, DH270 UCA3 Fab light chain
6UM5 Q2N0S7 Cryo-EM structure of HIV-1 neutralizing antibody DH270 UCA3 in complex with CH848 10.17DT Env Envelope glycoprotein gp41, Envelope glycoprotein gp120, DH270 UCA3 Fab heavy chain, DH270 UCA3 Fab light chain
6UM5 6UM5 Cryo-EM structure of HIV-1 neutralizing antibody DH270 UCA3 in complex with CH848 10.17DT Env Envelope glycoprotein gp41, Envelope glycoprotein gp120, DH270 UCA3 Fab heavy chain, DH270 UCA3 Fab light chain
6ORP 6ORP Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab897NHP Envelope glycoprotein gp41, Envelope glycoprotein gp120, Ab897NHP antibody Fab heavy chain, Ab897NHP antibody Fab light chain
6ORQ 6ORQ Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab275MUR Envelope glycoprotein gp41, Envelope glycoprotein gp120, Ab275MUR antibody Fab heavy chain, Ab275MUR antibody Fab light chain
6OKP B3UEZ6 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP B3UES2 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP S6B291 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP 6OKP B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP S6B291 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP 6OKP B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP Q8N5F4 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP Q8N5F4 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP P01834 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6OKP P01834 B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain
6ORN 6ORN Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch bNAb 10-1074 Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain
6XRT Q2N0S6 Cryo-EM structure of SHIV-elicited RHA1.V2.01 in complex with HIV-1 Env BG505 DS-SOSIP.664 Envelope glycoprotein gp41, BG505 gp120, VRC01.23 Light chain, VRC01.23 Heavy chain
6XRT 6XRT Cryo-EM structure of SHIV-elicited RHA1.V2.01 in complex with HIV-1 Env BG505 DS-SOSIP.664 Envelope glycoprotein gp41, BG505 gp120, VRC01.23 Light chain, VRC01.23 Heavy chain
6NNJ Q2N0S6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to CH31 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.1 Angstrom Envelope glycoprotein gp41, 35O22 scFv heavy chain, 35O22 scFv light chain, Envelope glycoprotein gp120, 3H109L Fab heavy chain, 3H109L Fab light chain, N6 FR3-03 heavy chain, N6 FR3-03 light chain
6NNJ 6NNJ Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to CH31 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.1 Angstrom Envelope glycoprotein gp41, 35O22 scFv heavy chain, 35O22 scFv light chain, Envelope glycoprotein gp120, 3H109L Fab heavy chain, 3H109L Fab light chain, N6 FR3-03 heavy chain, N6 FR3-03 light chain
6NM6 Q2N0S6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to N6 FR3-03 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.2 Angstrom Envelope glycoprotein gp41, 35O22 scFv heavy chain, 35O22 scFv light chain, Envelope glycoprotein gp120, 3H109L Fab heavy chain, 3H109L Fab light chain, N6 FR3-03 heavy chain, N6 FR3-03 light chain
6NM6 6NM6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to N6 FR3-03 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.2 Angstrom Envelope glycoprotein gp41, 35O22 scFv heavy chain, 35O22 scFv light chain, Envelope glycoprotein gp120, 3H109L Fab heavy chain, 3H109L Fab light chain, N6 FR3-03 heavy chain, N6 FR3-03 light chain
6DFG Q2N0S6 BG505 MD39 SOSIP trimer in complex with mature BG18 fragment antigen binding Envelope glycoprotein gp160, mature BG18 fragment antigen binding heavy chain, mature BG18 fragment antigen binding light chain
6DFG Q2N0S8 BG505 MD39 SOSIP trimer in complex with mature BG18 fragment antigen binding Envelope glycoprotein gp160, mature BG18 fragment antigen binding heavy chain, mature BG18 fragment antigen binding light chain
6DFG 6DFG BG505 MD39 SOSIP trimer in complex with mature BG18 fragment antigen binding Envelope glycoprotein gp160, mature BG18 fragment antigen binding heavy chain, mature BG18 fragment antigen binding light chain
6DFH Q2N0S6 BG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen binding Envelope glycoprotein gp160, germline-reverted BG18 fragment antigen binding heavy chain, germline-reverted BG18 fragment antigen binding light chain
6DFH Q2N0S5 BG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen binding Envelope glycoprotein gp160, germline-reverted BG18 fragment antigen binding heavy chain, germline-reverted BG18 fragment antigen binding light chain
6DFH 6DFH BG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen binding Envelope glycoprotein gp160, germline-reverted BG18 fragment antigen binding heavy chain, germline-reverted BG18 fragment antigen binding light chain
5VN8 B3UEZ6 Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain
5VN8 B3UES2 Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain
5VN8 5VN8 Cryo-EM model of B41 SOSIP.664 in complex with fragment antigen binding variable domain of b12 Envelope glycoprotein gp160, b12 Fab heavy chain, b12 Fab light chain
6MEO P01730 Structural basis of coreceptor recognition by HIV-1 envelope spike Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, C-C chemokine receptor type 5
6MEO P51681 Structural basis of coreceptor recognition by HIV-1 envelope spike Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, C-C chemokine receptor type 5
6MEO Q70145 Structural basis of coreceptor recognition by HIV-1 envelope spike Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, C-C chemokine receptor type 5
6MET P01730 Structural basis of coreceptor recognition by HIV-1 envelope spike Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, C-C chemokine receptor type 5

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024